US FDA grants efanesoctocog alfa breakthrough therapy designation for hemophilia A EP News Bureau Jun 2, 2022 The designation is based on Xtend-1 phase-III study data demonstrating a clinically meaningful prevention of bleeds and…
US antitrust enforcers give Roche approval to buy Spark Therapeutics Reuters Dec 17, 2019 The FTC approved the deal, which was originally announced in February, without requiring any asset sales to ensure that the…
